Short Interest in Oxford Biomedica plc (OTCMKTS:OXBDF) Drops By 66.7%

Oxford Biomedica plc (OTCMKTS:OXBDF - Get Free Report) was the target of a large drop in short interest in September. As of September 30th, there was short interest totalling 100 shares, a drop of 66.7% from the September 15th total of 300 shares. Based on an average trading volume of 5,600 shares, the short-interest ratio is currently 0.0 days.

Get Oxford Biomedica alerts:

Oxford Biomedica Price Performance

OXBDF stock remained flat at $5.02 during midday trading on Thursday. The company has a fifty day simple moving average of $4.58 and a 200 day simple moving average of $3.99. Oxford Biomedica has a one year low of $2.09 and a one year high of $5.02. The company has a current ratio of 2.35, a quick ratio of 2.07 and a debt-to-equity ratio of 1.48.

About Oxford Biomedica

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

Should you invest $1,000 in Oxford Biomedica right now?

Before you consider Oxford Biomedica, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oxford Biomedica wasn't on the list.

While Oxford Biomedica currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here